Sep 21, 2021

Talks with Docs: Douglas Sborov, Multiple Myeloma Director at HCI

Douglas Sborov, MD, MS, discusses the work being done by the multiple myeloma and clinical trials programs at Huntsman Cancer Institute. He also shares why this work is so meaningful and how a Robin Williams character resonates with him in this latest Talks with Docs.

Sep 02, 2021

Helping Non-English Speakers Take Part in Clinical Trials

“The gift that clinical trial participation gives—not only to science but to our patients—should not be limited by language,” says Sadie Gabler, director of the University of Utah Office of Research Participant Advocacy. She explains why clinical trial translation and interpretation services are a crucial part of the effort to reduce health disparities.

Aug 23, 2021

Ask an Expert: What is Amyloidosis?

Amyloidosis is a rare disease and researchers are trying to find new treatments for the disease. Huntsman Cancer Institute's Amandeep Godara, MBBS, tells you more about the disease, including its causes, symptoms and possible treatments.

Aug 05, 2021

How Cyclotrons Play a Crucial Role in Cancer Treatment

A cyclotron manufactures radiopharmaceuticals for positron emission tomography (PET) scans, which help doctors see where cancer is located inside the body. Huntsman Cancer Institute director of cyclotron operations, Brandon Buckway, explains how the cyclotron is a crucial tool in treating people with cancer.

Jul 19, 2021

Revolutionary Immunotherapy and Ben & Jerry’s: A Melanoma Patient’s Story

Max Rosett faced melanoma as a young adult and a decade later, he is cancer free. He describes how he felt after being diagnosed, the outstanding treatment he received at Huntsman Cancer Institute and the revolutionary immunotherapy clinical trials that helped save his life.

Jul 16, 2021

Talks with Docs: Adriana Coletta, Exercise and Cancer Researcher

Adriana Coletta, PhD, MS, RD, discusses the amazing new work being done for metastatic prostate cancer patients, what the future of exercise cancer research could look like, and her violin skills in the latest Talks with Docs.

May 21, 2021

Innovative National Clinical Trials in Breast Cancer and Hematologic Cancers Open at Huntsman Cancer Institute

Huntsman Cancer Institute highlights two examples of clinical trials at HCI exploring new innovations in cancer, including the I-SPY2 trial, studying new approaches for breast cancer treatment, and the SWOG CLL Study S1925, or EVOLVE CLL, an international study evaluating a new approach to chronic lymphocytic leukemia or small lymphocytic lymphoma.

Apr 01, 2021

Bringing Hope Closer to Cancer Patients

Clinical trials bring hope to patients in the form of innovative treatments. During the COVID-19 pandemic, despite strict hospital safety protocols and staff switching to remote work, HCI clinical research teams found a way to make sure patients could safely enroll and stay on clinical trials—remaining steadfast in our commitment to bring promising research advances to patients.

Mar 23, 2021

New Guidance for Clinical Trial Participation by Cancer Patients Receiving a COVID-19 Vaccination

An international group of cancer clinical research experts reported new recommendations that receiving a COVID-19 vaccination should not preclude a cancer patient from participating on a clinical trial. Huntsman Cancer Institute physician-scientist and professor of internal medicine at the University of Utah, Neeraj Agarwal, MD, was part of this newly formed group who reviewed the data and provided recommendations to patients, doctors, research centers, and the pharmaceutical research industry on this critical, emerging issue.

Dec 07, 2020

Huntsman Cancer Institute Treats First Non-Small Cell Lung Cancer Patient on New Phase I Clinical Trial

The first patient in the world to be enrolled on a clinical trial of a new investigational drug, AN0025, was treated at Huntsman Cancer Institute at the University of Utah earlier this year. The drug is being studied for use in patients with non-small cell lung cancer and other solid tumors who have previously been treated with immunotherapy and whose cancers later developed ways to resist immunotherapy.

Nov 18, 2020

A Clinical Trial Helped This Lung Cancer Patient Breathe Easy

When Scott Vance went in for a COVID-19 test, he never expected it would lead to a diagnosis of stage IV lung cancer. Scott’s doctors learned a specific mutation was causing the cancer, and he began a new mutation-targeting drug approved by the FDA just two years earlier. Scott says his remarkable response to the drug has him feeling grateful clinical trials can bring these cutting-edge treatments to people like him.

May 29, 2020

Huntsman Cancer Institute Researchers Demonstrate Better Outcomes, Lower Cost in First-Ever Oncology Hospital-at-Home Evaluation

Researchers at Huntsman Cancer Institute at the University of Utah presented the first outcomes evaluation of an adult oncology hospital-at-home program today at the 2020 American Society of Clinical Oncology annual meeting. The study evaluated patients participating in HCI’s Huntsman at HomeTM. The data demonstrate strong evidence for this care model, showing improved patient outcomes, including reduced hospitalizations and decreased visits to the emergency department.

Mar 01, 2020

De la noción al conocimiento: la investigación oncológica salva vidas

Las pruebas clínicas en Huntsman Cancer Institute (HCI por sus siglas en inglés) ayudan a encontrar mejores formas de prevenir, diagnosticar y tratar el cáncer, al poner a prueba la seguridad y efectividad de nuevos fármacos y tratamientos. En promedio, existen 150-200 ensayos clínicos abiertos a pacientes de HCI en cualquier momento dado.

Mar 01, 2020

From Notion to Knowledge: Cancer Research Saves Lives

Clinical trials at Huntsman Cancer Institute (HCI) help find better ways to prevent, diagnose, and treat cancer by testing the safety and effectiveness of new drugs and treatments. On average, there are between 150–200 clinical trials open to HCI patients at any given time.

Mar 12, 2019

Huntsman Translational Scholars: Matthew Poppe, MD

Huntsman Cancer Institute (HCI) has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Translational researchers extend basic discoveries made in the laboratory and apply them to solve clinical problems and benefit patients through new diagnostic and therapeutic approaches.

Mar 07, 2019

Why Is Pancreatic Cancer So Deadly?

Compared to other cancers, pancreatic cancer is relatively rare. But it is the third leading cause of cancer death in the United States. Only about 8.5% of patients with pancreatic cancer are alive five years after their diagnosis. This one of the lowest survival rates for any kind of cancer. What makes pancreatic cancer so deadly?

Mar 01, 2019

Exercise for Improved Outcomes

The Precision Exercise Prescription study is a unique collaboration between medical doctors, researchers, physical therapists, and patients. The study looks at how an exercise program tailored for each patient can improve long-term outcomes after lung cancer surgery.

Mar 01, 2019

Pancreas Discovery Moves from Lab to Clinic

In less than three years, HCI researchers have taken an idea from concept to lab to clinical evaluation. Conan Kinsey, MD, PhD, and Martin McMahon, PhD, combined two drugs that had not been used in combination before to treat pancreatic tumors. The results were promising and they were able to move from the lab to clinical trial quickly. A clinical trial to test the safety and effect of this drug combination in pancreatic cancer is now underway at HCI and planned at other sites around the United States.

Mar 01, 2019

A Passion for Advancing Research and Improving Patient Care

HCI patient Clark Stringham felt like he was running out of time with his diagnosis of advanced prostate cancer. He credits a clinical trial and his oncologist, Neeraj Agarwal, MD, with saving his life.

Mar 01, 2019

Clinical Trials: A Look at Recent Progress

Clinical trials test the safety and effectiveness of new cancer drugs and treatments. They help us find better ways to prevent, diagnose, or treat cancer. At any given time, Huntsman Cancer Institute has an average of 200 clinical trials open to cancer patients.

Mar 01, 2019

Advancing Hematologic Cancer Research and Care

The Center of Excellence in Hematologic Malignancies and Hematology at Huntsman Cancer Institute is a group of more than three dozen doctors and scientists dedicated to hematologic cancers such as leukemia, lymphoma, and multiple myeloma. Integration and collaboration across disciplines will improve clinical care and advance research in these complicated diseases.

Feb 08, 2019

Last Year’s Biggest Advances in Cancer Research

The American Society of Clinical Oncology recently published Clinical Cancer Advances, their 2019 annual report on the progress against cancer. The report examines the most transformative research of the past year and looks ahead to future research priorities. Two physician-scientists from Huntsman Cancer Institute contributed to the report.

Nov 15, 2018

Huntsman Cancer Institute Announces New Phase I Clinical Trial Director

Huntsman Cancer Institute at the University of Utah has appointed Ignacio Garrido-Laguna, MD, PhD, as director of its Phase I Clinical Trials unit. In this position, Garrido-Laguna will oversee all aspects of HCI’s Phase I clinical trials.

Sep 19, 2018

Huntsman Translational Scholars: Ignacio Garrido-Laguna, MD, PhD

Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Ignacio Garrido-Laguna, MD, PhD, is a physician-scientist who treats patients with pancreatic cancer.

Jul 31, 2018

Huntsman Translational Scholars: Howard Colman, MD, PhD

Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Howard Colman, MD, PhD is a physician-scientist specializing in the treatment of brain tumors and the diagnosis and management of neurologic complications of cancer.

Jul 09, 2018

Huntsman Translational Scholars: Adam Cohen, MD, MS

Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Adam Cohen, MD, MS, was recently honored with a Huntsman Translational Scholar award. He is a researcher and physician, specializing in neuro-oncology and breast oncology.

Jul 05, 2018

What Is Glioblastoma? HCI Brain Tumor Experts Explain

We asked the experts at Huntsman Cancer Institute about symptoms, diagnosis, and treatment of glioblastoma.

Jun 21, 2018

5 Questions about Clinical Trials

Are you thinking about taking part in a clinical trial? Read these five frequently asked questions about clinical trials.

May 23, 2018

Huntsman Translational Scholars: Deborah Stephens, DO

HCI established the Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Deborah Stephens, DO, was recently honored with a Huntsman Translational Scholar award. She is the physician leader of Hematology Clinical Trials at Huntsman Cancer Institute and is also an assistant professor in the Division of Hematology and Hematologic Malignancies at the University of Utah.

May 09, 2018

Huntsman Translational Scholars: Theresa Werner, MD

HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Theresa Werner, MD, was recently honored with a Huntsman Translational Scholar award. She is the medical director of Clinical Trials and treats patients with gynecologic cancers.

Mar 08, 2018

Talks with Docs: Theresa Werner, MD

Huntsman Cancer Institute celebrates International Women's Day 2018 in a conversation with Dr. Theresa Werner. Her patients juggle treatment with lives that often include work, a relationship, and motherhood. She talks with us about the optimistic women she treats in clinic and a stylish first lady of the United States she would trade lives with for a day.

Feb 15, 2018

Developing Better Targeted Therapies

Targeted therapy in cancer treatment is often called personalized or precision medicine, according to the National Institutes of Health. Targeted therapies are designed to be more effective and less harmful than other approaches because the drugs are specially designed to meet the individual characteristics of each patient.

Feb 15, 2018

Expanding Access to Clinical Trials

All cancer treatments and medications that are used today were, at one point, part of a clinical trial. Clinical trials can offer hope, particularly in complex diseases such as cancer. But getting access to them can be difficult, especially if patients have to travel a long distance to a hospital that offers trials.

Nov 14, 2017

Can Immunotherapy Help Patients with Pancreatic Cancer?

Immunotherapy has shown to be an effective treatment for several types of cancer. Is pancreatic cancer one of them? Ignacio Garrido-Laguna, MD, PhD, answers that question during Pancreatic Cancer Awareness Month.

Jul 07, 2017

Cancer Summit Highlights Advances in Immunotherapy

Our bodies fight cancer more than we really know, says Dr. Kenneth Grossmann. And, he adds, advances in medicine can help the immune system fight cancer even better.

Jun 26, 2015

The Art and Science of Clinical Research Coordination

Walking into clinic, I found the patient and his wife looking tired and apprehensive. From what I knew of his medical history, his cancer had not responded to any standard treatments, each drug failing to restrain the tumor’s advance for more than a few months. The patient and his wife had talked to their local cancer doctor about clinical trials, had traveled hundreds of miles to Huntsman Cancer Institute, and were clearly anxious to begin the discussion.